Article

Clinical Efficacy and Safety of Ceftriaxone in Surgical Prophylaxis: A Systematic Review and Meta-Analysis

Shwetha Somakumar1, S Elstin Anbu Raj1, Gabriel Sunil Rodrigues2, V Rajesh3★★ Corresponding author

  1. 1Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, INDIA.
  2. 2Department of General and Laparoscopic Surgery, Aster Al Raffah Hospital, Sohar, OMAN.
  3. 3Centre for Pharmaceutical Care, Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, INDIA.

CORRESPONDENCE

V Rajesh

Dr. Rajesh V, M.Pharm, Ph.D. Associate Professor, Centre for Pharmaceutical Care, Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal-576104, Karnataka, INDIA.

rajesh.v@manipal.edu

ORCID: 0000-0003-1261-4977

Received: 10-06-2023; Revised: 12-09-2023; Accepted: 14-01-2024.

Volume 58, Issue 2S · pp. s332–s339 · PUBLISHED Apr-Jun 2024 · DOI: 10.5530/ijper.58.2s.36

View on IJPER original site ↗

ABSTRACT

Introduction Adequate antimicrobial monitoring helps identify the changing pattern of infection prevention postoperatively. The review aims at assessing the efficacy and safety of prophylactic ceftriaxone in surgical site infection. Materials and Methods The review followed Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. A systematic search was conducted in PubMed, EMBASE, and CINAHL databases. Randomized control trials, published till December 2022 in English, studying only preoperative ceftriaxone, and focusing on general surgical procedures were included. Meta-analysis was done using review manager software. Results Of the 2961 articles, nine were included in the review. Elevated gram-positive (33%) and gram-negative (67%) isolates were observed from the surgical site post-prophylaxis. Surgical site infection was developed in 53 (3.41%) patients in the ceftriaxone group and 108 (6.9%) patients in the comparator groups [OR 0.47 (95% CI: 0.33-0.65), p <0.0001]. Adverse events were assessed in six studies, from which 111 (21.4%) and 163 (31.2%) patients in the intervention and comparator groups developed the same [RR: 0.56 (95% CI: 0.31-1.01), p=0.06]. An overall estimate of [MD: -1.12 (95%CI: -1.36 to -0.89), p<0.00001)] was obtained on assessing hospital stays in the included articles. Conclusion The evidence generated identified various microbial isolates from the infected sites. The drug assured its efficacy profile in surgical prophylaxis. More studies in general surgery can give a better conclusion about ceftriaxone prophylaxis.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Somakumar, S., Raj, S. E. A., Rodrigues, G. S., & Rajesh, V. (2024). Clinical Efficacy and Safety of Ceftriaxone in Surgical Prophylaxis: A Systematic Review and Meta-Analysis. Indian Journal of Pharmaceutical Education and Research, 58(2S), s332–s339. https://doi.org/10.5530/ijper.58.2s.36